Clinical Trials in Alabaster, Alabama

Find clinical trials in Alabaster, Alabama. Discover local research opportunities and treatment options in your area.

5 Active Trials Found in Alabaster

Showing 5 trials on this page

Page 1 of 1

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

NCT ID: NCT06747572

This clinical trial is focused on understanding more about a genetic condition called Autosomal Dominant Polycystic Kidney Disease (ADPKD), specifically looking at the PKD1 and PKD2 gene variants t...

Recruiting

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease

NCT ID: NCT05312879

This clinical trial is studying a new treatment called VX-147 for patients with a specific type of kidney disease known as APOL1-mediated proteinuric kidney disease. This condition can lead to prot...

Recruiting

Phase: PHASE2 Conditions: Proteinuric Kidney Disease

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT ID: NCT06291376

This clinical trial is studying a medication called ravulizumab to see if it can help adults with a kidney condition known as Immunoglobulin A Nephropathy (IgAN). The main goals are to find out if ...

Recruiting

Phase: PHASE3 Conditions: Immunoglobulin A Nephropathy, IgAN

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

NCT ID: NCT06824987

This clinical trial is studying a new medication called AZD2373 to see how safe and effective it is for people with a specific type of kidney disease known as APOL1-Mediated Kidney Disease (AMKD). ...

Recruiting

Phase: PHASE2 Conditions: APOL1-Mediated Kidney Disease

Search All Trials Browse All Locations